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Racial and ethnic differences in smoking
changes after chronic disease diagnosis
among middle-aged and older adults in
the United States
Ana R. Quiñones1,2*, Corey L. Nagel1,3, Jason T. Newsom4, Nathalie Huguet5, Paige Sheridan1
and Stephen M. Thielke6,7

Abstract
Background: Middle-aged and older Americans from underrepresented racial and ethnic backgrounds are at risk
for greater chronic disease morbidity than their white counterparts. Cigarette smoking increases the severity of
chronic illness, worsens physical functioning, and impairs the successful management of symptoms. As a result,
it is important to understand whether smoking behaviors change after the onset of a chronic condition. We assessed
the racial/ethnic differences in smoking behavior change after onset of chronic diseases among middle-aged and older
adults in the US.
Methods: We use longitudinal data from the Health and Retirement Study (HRS 1992–2010) to examine changes in
smoking status and quantity of cigarettes smoked after a new heart disease, diabetes, cancer, stroke, or lung disease
diagnosis among smokers.
Results: The percentage of middle-aged and older smokers who quit after a new diagnosis varied by racial/
ethnic group and disease: for white smokers, the percentage ranged from 14% after diabetes diagnosis to 32%
after cancer diagnosis; for black smokers, the percentage ranged from 15% after lung disease diagnosis to 40%
after heart disease diagnosis; the percentage of Latino smokers who quit was only statistically significant after
stoke, where 38% quit. In logistic models, black (OR = 0.43, 95% CI: 0.19–0.99) and Latino (OR = 0.26, 95% CI: 0.11–0.65)
older adults were less likely to continue smoking relative to white older adults after a stroke, and Latinos were more
likely to continue smoking relative to black older adults after heart disease onset (OR = 2.69, 95% CI [1.05–6.95]).
In models evaluating changes in the number of cigarettes smoked after a new diagnosis, black older adults smoked
significantly fewer cigarettes than whites after a new diagnosis of diabetes, heart disease, stroke or cancer, and Latino
older adults smoked significantly fewer cigarettes compared to white older adults after newly diagnosed diabetes and
heart disease. Relative to black older adults, Latinos smoked significantly fewer cigarettes after newly diagnosed diabetes.
Conclusions: A large majority of middle-aged and older smokers continued to smoke after diagnosis with a major
chronic disease. Black participants demonstrated the largest reductions in smoking behavior. These findings have
important implications for tailoring secondary prevention efforts for older adults.
Keywords: Racial/ethnic disparities, Smoking, Behavior change, Chronic disease, Disease management
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Background
Higher mortality and morbidity burdens continue to disproportionately accrue to individuals from underrepresented racial and ethnic backgrounds into middle and
old age [1–4]. Chronic disease complications are largely
preventable with timely and effective care, and by having
responsive disease management plans in place. Smoking
is widely recognized as the main modifiable risk factor
to prevent exacerbations of existing chronic disease and
avert the development of incident chronic conditions.
As a result, effecting changes in smoking behavior are
among the first line of recommended actions to avert
onset of cardiovascular disease, pulmonary disease, and
various forms of cancer [5].
There are important differences in chronic disease
morbidity and mortality for underrepresented racial and
ethnic groups relative to whites. Both US-born Latinos
and black Americans have greater smoking-related mortality than white Americans [5], and contend with significantly higher rates of cardiovascular and metabolic
disease than whites even into older age [6]. Efforts to encourage behavior change after health problems have
already set in (i.e., secondary prevention efforts) are critical
to meeting public health goals of effective chronic disease
management and health maintenance for older adult populations [7]. In addition, promotion of smoking cessation
programs in late life may help in averting adverse events
such as cancer recurrence, repeated heart attacks, and exacerbations in disease severity for older adult smokers that
remain resistant to quitting [8–10]. A new chronic disease
diagnosis could potentially serve as a warning, precipitating
health behavior change and increased self-health vigilance
[11, 12], or a “teachable moment” to intervene on adults
with newly diagnosed chronic conditions [13–15]. Indeed,
a small number of studies find that new health problems
may actually improve the health and health habits of older
adults [7, 10, 16].
There is little information about whether cessation
attempts at older ages are more or less likely across racial and ethnic groups, and these differences may be an
important source of disparities in health, including disease prevalence, prognosis after diagnosis, and quality
of life.
While health behaviors are widely recognized as influential contributors to morbidity and mortality for the
adolescent and young adult population [8], less attention
has been focused on the effectiveness of smoking behavior
modification among older adults [17–19]. Further, the
adoption and maintenance of healthful behaviors—such
as smoking reductions and cessation—may be of particular importance in the prevention of disease and compromised function associated with aging [18, 19].
The purpose of this study is to assess whether the
onset of chronic disease elicits differential changes to
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smoking behaviors between black, Latino, and white
older adults. To date, little is known about whether
older adults from various racial and ethnic backgrounds
are more or less likely to make lifestyle modifications in
response to adverse changes to their health. These
insights are critical in evaluating illness perception and
behavior change as well as in assessing the adequacy and
availability of secondary prevention efforts for underrepresented racial and ethnic older adults.

Methods
Data

This study uses data from the Health and Retirement Study
(HRS), a nationally-representative sample of communitybased adults over age 50 identified through screening of an
area probability sample of households. The original
HRS study cohort (born between 1942 and 1947) was
first interviewed in 1992 and has since continued to be
re-interviewed on a biennial basis. A detailed description of the HRS study design has been published elsewhere [20, 21] and publicly-available data files can be
found on the HRS website (http://hrsonline.isr.umich.edu). The Institutional Review of the University of
Michigan approved the Health and Retirement Study.
As secondary data analysis of existing, de-identified
survey data, the current study was exempt from human
subject review by the Institutional Review Board of
Oregon Health & Science University.
We examined data from 18,843 HRS respondents surveyed between the years of 1992–2010 who reported
having at least one of the chronic conditions we studied
(i.e., heart disease, diabetes, cancer, stroke, or lung disease)
during the study period. 12,572 respondents reported a
chronic condition that was not present at a previous wave.
We made the following exclusions to arrive at our analytic
sample: (1) 1014 respondents were age-ineligible spouses
or had a zero sampling weights; (2) 549 respondents were
missing in the pre-diagnosis wave (i.e., the immediately
preceding wave from when the condition was reported);
(3) 717 respondents reported their race as other/missing;
and (4) 1243 respondents had missing smoking data. The
resulting analytic sample consisted of 9049 individuals
who were diagnosed with at least one of the chronic conditions of diabetes, heart disease, stroke, cancer, or lung
disease at a follow-up interview.
Design

This study included twelve waves of HRS data spanning
18 years (1992 to 2010). Analyses were based on all
available waves of data for which items were worded
consistently. We defined pre-illness diagnosis and postillness diagnosis time points for each individual study
respondent. The pre-diagnosis time point was defined as
the last wave of interview prior to diagnosis. The post-
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diagnosis time point was defined as the same wave at
which a respondent reported a new chronic disease, and,
thus occurred between 0 and 2 years after the diagnosis.
We included only participants who report a new diagnosis, and have valid smoking status (i.e., non-missing) in
pre- and post diagnosis time points.
Measures
Main outcome: current smoking status

The main outcome measure in this study was current
smoking behavior, which was operationalized in two
ways: (1) a binary indicator for current smoking status
asked in the HRS questionnaire, “Do you smoke cigarettes now?” (1 = yes; 0 = no), and (2) a continuous variable for the number cigarettes smoked asked in the HRS
questionnaire, “About how many cigarettes or packs do
you usually smoke in a day now?” Smoking variables are
available for all years of the survey to date (1992–2010).
Chronic disease indicators

We assessed changes in smoking behavior following
new, incident disease. In order to ascertain disease status, the HRS asked study participants a series of questions beginning with, “Has a doctor ever told you that
you had…” for the following list of conditions, “a heart
attack, coronary heart disease, angina, congestive heart
failure, or other heart problems?”; “diabetes or high
blood sugar?”; “cancer or a malignant tumor of any kind
except skin cancer?”; “stroke?”; and “chronic lung disease
such as chronic bronchitis or emphysema?” Participants
who indicated “yes” to any of these questions were considered to have a disease diagnosis for the corresponding
disease. Each disease was examined separately regardless
of the number of comorbid conditions present in participants with more than one disease diagnosis. Study participants with a new disease diagnosis following no
disease diagnosis in the previous study wave were classified as having new disease onset.
Demographic and socioeconomic covariates

We used a set of dummy variables to represent differences
among mutually-exclusive categories for non-Latino white
(white), non-Latino black (black) and Latino individuals.
We constructed dummy variables for white, black, and
Latino included in the models to enable comparison
between black vs. white, Latino vs. white, and Latino
vs. black.
In addition to race and ethnicity, several demographic,
socioeconomic, and health status factors were adjusted
for in the analyses. We included age (number of years),
female gender, education (high school graduate or not),
income (in thousands of dollars), insurance coverage (insured or not), and marital status (partnered or not). Selfrated health was measured using a single question with
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five response categories prompting respondents to rate
their own health as “excellent,” “very good,” “good,”
“fair,” or “poor” (1–5, with 5 indicating “excellent” selfassessed health). Functional limitations were measured
by difficulties with activities of daily living (e.g., dressing,
bathing, eating) and instrumental activities of daily living
(e.g., walking across a room, preparing a hot meal)
assessed at the interview following a new diagnosis (“Because of a health problem do you have any difficulty…?”). Participants who indicated “yes” to any of the
questions were considered to have some functional impairment. Because disease severity is not captured in the
public release HRS data, including functional limitations
and self-rated health as covariates may provide an indication of the severity of comorbid conditions that study
participants contend with. Comorbidity was included as
a total count of additional chronic conditions (heart disease, diabetes, stroke, cancer, lung disease, hypertension,
and arthritis) for individuals prior to being diagnosed with
the new condition in question. Age, gender, education, income, and marital status were measured at the prediagnosis time point. Income, insurance coverage, functional limitations, self-rated health, and comorbidity were
measured at the post-diagnosis time point.
Analysis

All statistical analyses were weighted for nonresponse
and post-stratification and adjusted for complex sampling with SAS software, version 9.2 (SAS Institute Inc.,
Carey, North Carolina) according to recommendations
for analysis of the HRS [21]. Because standard procedures used to test for repeated measures differences in
proportions, such as the McNemar’s chi-square, are not
available with software used for sampling design adjustments, initial tests of differences in smoking proportions
without covariates were made using the Rao-Scott chisquare [22] comparing discordant cells (i.e., 0-1 vs. 1-0
responses) [23]. Paired t-tests were used to compare preand post-diagnosis means for continuous variables [24].
Logistic models were estimated to predict racial/ethnic
differences in smoking status change after the onset of a
chronic condition among former smokers and nonsmokers. Additional analyses examined the number of
cigarettes smoked per day only among smokers. We estimated negative binomial models to account for observed
overdispersion in the distribution of the number of cigarettes smoked [25] and report the exponentiated coefficients (ratio of means, or incident rate ratios). These
models investigated racial/ethnic differences in the quantity of cigarettes smoked after chronic disease diagnosis
among smokers (i.e., respondents that reported consistently smoking in all previous periods of observation). In
both sets of models (logistic and negative binomial), we
estimate smoking behaviors in the post-diagnosis period
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controlling for pre-diagnosis smoking and differences in
gender, age, education, functional limitations, self-rated
health, and comorbidity burden by race/ethnic group
membership.

Results
We identified 9049 middle-aged and older adults that
were included in the analysis (Table 1). In our study,
76% were white, 15% black, and 9% Latino. A slight minority of respondents were female (48.9%) and most had
at least high school education level (75.2%). At the first
post-diagnosis wave, respondents had an average age
was 67.2 years, with a mean of 4.7 functional limitations,
and 1.7 co-occurring chronic diseases.
Within-race/ethnic group smoking changes after
diagnosis

Table 2 presents weighted percentages, weighted counts
at pre-diagnosis and post-diagnosis (between 0 and
2 years following diagnosis) and percent change (i.e.,
percent who quit for the current smoking outcome, and
changes in the mean number of cigarettes smoked) for
white, black, and Latino respondents. These pre- and
post-diagnosis measures reflect the within race/ethnic
group temporal changes in smoking. Overall, reductions
in current smoker percentages were evident across all

three racial/ethnic groups after chronic disease onset,
with the exception of Latino respondents after diabetes
onset. The percentage of older adults who quit smoking
after a new diagnosis varied widely by racial/ethnic
group and disease. The percentage of white smokers
who quit ranged from 14% after diabetes diagnosis to
32% after cancer diagnosis. For black smokers, the percentage who quit ranged from 15% after lung disease
diagnosis to 40% after heart disease diagnosis. The percentage of Latino smokers who quit was only statistically
significant after stoke, where 38% quit.
Among respondents who continued to smoke after a
chronic disease diagnosis, significant reductions in the
mean number of cigarettes smoked were observed for
white middle-aged and older adults across any of the five
chronic diseases. Black respondents significantly reduced
mean cigarette consumption after newly diagnosed heart
disease, stroke, and cancer. Latino respondents significantly reduced the quantity of cigarettes smoked after
cancer and lung disease.
Between-race/ethnic group smoking changes after
diagnosis

Table 3 presents the estimated changes in current smoking
status after disease diagnosis controlling for differences in
demographic characteristics, socioeconomic factors, and

Table 1 Descriptive characteristics, HRS analytic sample 1992–2010
Measures

Total
N = 9049

White
n = 6903 (76%)

Black
n = 1368 (15%)

Latino
n = 778 (9%)

Heart Disease, %

44.3

45.1

39.6

40.6

Lung Disease, %

22.2

22.8

21.0

15.1

Cancer, %

27.7

28.7

26.0

16.9

Diabetes, %

31.0

28.9

38.5

46.6

Stroke, %

14.7

14.2

18.5

15.0

Age at diagnosis, mean

67.2

67.7

64.9

65.0

Female, %

48.9

48.1

54.5

49.8

New Diagnoses

High school graduate, mean

75.2

80.4

57.2

35.3

Income (thousands of dollars), mean

52.7

56.9

34.4

26.1

Insured, %

94.7

96.0

91.3

82.0

ADL/IADL score (0–11), mean

4.7

4.6

5.6

5.3

Comorbidity (0–7), mean

1.7

1.7

2.0

1.7

SRH (1–5)
Poor, %

14.8

13.7

20.6

21.0

Fair, %

28.4

26.1

37.8

43.8

Good, %

33.6

34.9

27.4

26.0

Very Good, %

19.1

20.8

12.0

7.4

Excellent, %

4.1

4.5

2.3

1.8

Covariate measures are assessed at the post-diagnosis time period. Means and proportions are weighted (post-diagnosis weight) and adjusted for complex sampling
design. Comorbidity is a count of self-reported arthritis, hypertension, diabetes, stroke, heart disease, lung disease and cancer
Acronyms: HRS Health and Retirement Study, ADL activities of daily living, IADL instrumental activities of daily living, SRH self-rated health
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Table 2 Within racial/ethnic group change in smoking in the period preceding and following chronic disease diagnosis, HRS
1992–2010
White

Black

Latino

N

Pre

Post

% Change

N

Pre

Post

% Change

N

Pre

Post

% Change

Current Smoker (%)

1954

19.7

16.9**

−14.2

526

27.1

22.0**

−18.7

354

15.5

15.6

+1.0

# Cigarettes (mean)

351

18.3

15.7*

−14.0

126

12.8

10.2

−20.2

54

8.4

7.8

−6.2

Current Smoker (%)

3142

20.7

14.3**

−30.9

536

30.2

18.1**

−40.1

312

22.1

18.8

−15.0

# Cigarettes (mean)

607

18.4

11.5**

−37.5

140

12.1

6.0**

−50.5

55

9.8

9.5

−3.6

Current Smoker (%)

1024

22.5

18.6**

−17.5

264

32.9

23.3**

−29.2

128

30.4

19.0**

−37.6

# Cigarettes (mean)

202

18.1

14.9**

−17.8

69

13.3

9.4*

−29.3

33

11.5

10.1

−12.2

Current Smoker (%)

1963

20.7

14.1**

−32.0

357

30.0

21.4**

−28.6

154

22.1

15.2

−31.2

# Cigarettes (mean)

278

18.9

12.0**

−36.5

55

11.9

7.8**

−34.2

20

11.7

9.8**

−16.1

Current Smoker (%)

1539

41.7

33.8**

−18.9

273

45.8

38.8**

−15.3

119

36.6

34.8

−5.0

# Cigarettes (mean)

613

19.4

14.0**

−27.9

111

11.1

11.3

+1.7

36

13.7

7.9**

−42.4

Diabetes

Heart disease

Stroke

Cancer

Lung disease

Within-group change in health behavior was assessed using Rao–Scott chi square tests to compare pre- and post-diagnosis proportions for categorical outcomes
and paired t-tests to compare pre- and post-diagnosis means for continuous outcomes. All analyses are weighted (post-diagnosis weight) and adjusted for
complex sampling design using SAS 9.2. The “% Change” column represents percentage who quit for the current smoker outcome and changes in cigarettes
smoked for # cigarettes outcome. Statistical test significance levels: * < .05; ** < .01
Acronym: HRS Health and Retirement Study

Table 3 Between racial/ethnic groupa change in smoking in the period preceding and following chronic disease diagnosis, HRS
1992–2010
Diabetes

Heart Disease

Post- diagnosis smoker Post- diagnosis smoker
(n = 2796)
(n = 4055)
OR

Stroke

Cancer

Lung Disease

Post- diagnosis smoker Post- diagnosis smoker Post- diagnosis smoker
(n = 1515)
(n = 2434)
(n = 1978)

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

White (reference group) -

-

-

-

-

-

-

-

-

-

Black

0.75

0.44–1.32

0.69

0.41–1.15

0.43*

0.19–0.99

0.9

0.45–1.80

0.98

0.52–1.84

Latino

1.02

0.52–1.98

1.86

0.77–4.52

0.26**

0.11–0.65

0.54

0.18–1.58

1.09

0.41–2.89

Age (years)

0.97*

0.94–0.99

0.97**

0.95–0.99

0.95**

0.92–0.98

0.98

0.95–1.00

0.97**

0.95–0.99

Female

0.92

0.60–1.42

1.67**

1.20–2.34

1.00

0.59–1.69

1.00

0.65–1.52

1.44

0.99–2.09

Education (years)

0.98

0.91–1.06

1.01

0.95–1.00

0.89**

0.82–0.96

0.92

0.85–1.00

0.95

0.89–1.01

Income (thousands)

1.00

0.99–1.00

1.00

0.99–1.00

0.99

0.98–1.00

0.99*

0.98–0.99

1.00

0.99–1.00

Insured

1.17

0.38–3.60

1.09

0.52–2.31

1.22

0.41–3.61

0.59

0.22–1.58

0.68

0.34–1.35

ADL/IADL score (0–11)

1.01

0.92–1.10

0.95

0.89–1.01

0.95

0.86–1.04

0.90*

0.83–0.98

0.95

0.89–1.02

Comorbidity (0–7)

0.84

0.66–1.07

0.92

0.79–1.08

1.00

0.79–1.26

1.16

0.94–1.42

0.90

0.75–1.08

SRH (1–5)

0.79

0.61–1.02

0.92

0.75–1.14

0.9

0.65–1.24

0.90

0.73–1.12

0.92

0.74–1.15

Pre-diagnosis smoker

113.06** 69.25–184.60 109.18** 70.77–168–45 105.76** 55.01–203.37 82.53**

47.14–144.51

70.38**

45.74–108.31

All model covariates as assessed at the post-diagnosis time period. All analyses were weighted (post-diagnosis weight) and adjusted for complex sampling design
using SAS 9.2. Statistically significant racial/ethnic differences in smoking change are bolded. Binary models estimate post-diagnosis smoking behavior controlling
for pre-diagnosis status
Acronyms: HRS Health and Retirement Study, OR odds ratios, IRR incidence rate ratios
a
White as reference group. Statistical test significance levels: * < .05; ** < .01
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health status covariates for black and Latino relative to
white respondents. We also estimate the same model in
Additional file 1: Table A1, with black as the race/ethnic
reference group. Pre-diagnosis smoking was included to
account for initial racial/ethnic differences in smoking.
The logistic regression provides the odds of smoking postdiagnosis given the odds of smoking initially after controlling for covariates. Relative to middle-aged and older
whites, black (OR = 0.43, 95% CI: 0.19–0.99) and Latino
(OR = 0.26, 95% CI: 0.11–0.65) older adults were less likely
to continue smoking after a new onset of stroke. From
Additional file 1: Table A1, relative to black middle-aged
and older adults, Latinos were more likely to continue
smoking after newly diagnosed heart disease (OR = 2.69,
95% CI: 1.05–6.95).
Table 4 presents the changes in the number of cigarettes smoked post-diagnosis for black and Latino relative to white smokers after controlling for the number of
cigarettes smoked in the pre-period as well as sociodemographic and health status covariates. We also estimate the same model in Additional file 2: Table A2, with
black as the race/ethnic reference group. Relative to
white middle-aged and older adults, black respondents
smoked 0.7 times fewer (95% CI: 0.54–0.91) cigarettes
after a new diagnosis of diabetes, 0.54 times fewer (95%
CI: 0.41–0.72) cigarettes after new heart disease, 0.53
times fewer (95% CI: 0.35–0.80) cigarettes after new
stroke, and 0.67 times fewer (95% CI: 0.47–0.96) cigarettes
after new cancer onset. Relative to white middle-aged and

older adults, Latino respondents smoked 0.42 times fewer
(95% CI: 0.29–0.62) cigarettes after newly diagnosed diabetes and 0.63 times fewer (95% CI: 0.44–0.90) cigarettes
after heart disease onset. From Additional file 2: Table A2,
relative to black middle-aged and older adults, Latino respondents smoked 0.6 times fewer (95% CI: 0.41–0.89)
cigarettes after newly diagnosed diabetes.

Discussion
The objective of this study was to investigate changes in
smoking behavior between black, Latino, and white
adults after a chronic illness diagnosis. Moderate-to-low
percentages of middle-aged and older adults quit smoking after the onset of a new chronic disease diagnosis,
and these varied widely by race/ethnic group and by
chronic disease type. Similarly, we found modest reductions in the quantity of cigarettes smoked for middleaged and older adults who continued to smoke after a
newly diagnosed chronic disease, and this too varied
widely by race/ethnic group and chronic disease type.
Although observed reductions represent some positive
change to smoking behavior among older adults, the
majority of respondents continued to smoke after being
diagnosis with a new illness.
The smoking patterns of older adults have been largely
ignored by researchers, who have focused predominantly
on younger adult smoking behaviors [26]. Among nonelderly adults, whites are more likely to quit at any given
time point, and importantly, black Americans—who

Table 4 Between racial/ethnic groupa change in number of cigarettes smoked among smokers in the period preceding and
following chronic disease diagnosis, HRS 1992–2010
Diabetes

Heart Disease

Stroke

Cancer

Lung Disease

Post-diagnosis
cigarettes smoked
(n = 490)

Post-diagnosis
cigarettes smoked
(n = 832)

Post-diagnosis
cigarettes smoked
(n = 317)

Post-diagnosis
cigarettes smoked
(n = 348)

Post-diagnosis
cigarettes smoked
(n = 758)

IRR

95% CI

IRR

95% CI

IRR

95% CI

IRR

95% CI

IRR

95% CI

White (reference group)

-

-

-

-

-

-

-

-

-

-

Black

0.70**

0.54–0.91

0.54**

0.41–0.72

0.53**

0.35–0.80

0.67*

0.47–0.96

1.02

0.77–1.35

Latino

0.42**

0.29–0.62

0.63*

0.44–0.90

0.78

0.40–1.53

0.89

0.47–1.68

0.62

0.35–1.10

Age (years)

0.98*

0.97–0.99

0.98*

0.97–0.99

1.00

0.98–1.02

0.98

0.96–1.00

0.99

0.98–1.00

Female

0.98

0.79–1.21

1.14

0.93–1.39

0.9

0.69–1.17

0.79

0.59–1.05

0.95

0.80–1.11

Education (years)

0.99

0.96–1.03

0.97*

0.94–0.99

1.00

0.96–1.05

0.95

0.91–1.00

0.98

0.95–1.02

Income (thousands)

1.00

0.99–1.00

1.00

0.99–1.00

1.00

0.99–1.00

0.99*

0.99–0.99

1.00

0.99–1.00

Insured

1.08

0.65–1.79

1.16

0.81–1.68

1.31

0.80–2.15

1.05

0.73–1.50

0.99

0.81–1.20

ADL/IADL score (0–11)

0.98

0.95–1.02

1.01

0.97–1.05

1.07*

1.01–1.13

0.98

0.93–1.03

0.96*

0.92–0.99

Comorbidity (0–7)

0.92

0.83–1.03

1.00

0.91–1.09

1.04

0.93–1.15

1.00

0.89–1.13

1.04

0.96–1.13

SRH (1–5)

0.87*

0.77–0.99

1.00

0.89–1.12

1.12

0.92–1.36

1.03

0.84–1.14

0.98

0.88–1.10

1.01–1.03

1.02**

1.01–1.03

1.03**

1.02–1.04

1.02**

1.02–1.04

1.03**

1.02–1.04

Pre-diagnosis cigarettes smoked 1.02**

All model covariates as assessed at the post-diagnosis time period. All analyses were weighted (post-diagnosis weight) and adjusted for complex sampling design
using SAS 9.2. Statistically significant racial/ethnic differences in smoking change are bolded
Acronyms: HRS Health and Retirement Study, OR odds ratios, IRR incidence rate ratios
a
White as reference group. Statistical test significance levels: * < .05; ** < .01
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predominantly smoke mentholated cigarettes—have
lower cessation rates and experience higher rates of
smoking-related health consequences relative to white
Americans despite smoking fewer cigarettes, on average
[27–29]. This literature provides a useful counterpoint
to our findings for middle-aged and older Americans of
relatively low smoking cessation across race/ethnic
groups in the face of health declines.
We found several interesting differences in smoking
behavior change between black, Latino, and white older
adults. Relative to whites, black and Latino respondents
were less likely to smoke after suffering a stroke. Stated
conversely, older white adults were less likely to quit
after stroke than were black and Latino older adults.
Comparing changes in smoking behavior between black
and Latino middle-aged and older adults, Latinos were
less likely to quit smoking after newly diagnosed heart
disease. Further, white middle-aged and older adults
smoked the greatest quantity of cigarettes despite health
downturns. Relative to whites, black participants smoked
fewer cigarettes after a new diabetes, heart disease,
stroke, or cancer diagnosis, and Latinos smoked fewer
cigarettes after a new diagnosis of diabetes or heart disease. These differences may have important health consequences for older adults—particularly older white
adults—who continue to smoke after chronic disease onset, which could lead to exacerbations and complications
of the disease, or other serious adverse events.
Efforts to promote health behavior change for individuals from socioeconomically and ethnically diverse
backgrounds have generated a nuanced discussion in
the literature. On one hand, high-risk and underserved
populations should be a focus of prevention efforts
given lower life expectancy in the US, greater likelihood
of cancer mortality, and greater likelihood of engaging
in risky health behaviors [30]. In addition, high prevalence of risky health behaviors—smoking in particular—among disadvantaged older adults may contribute
to maintaining inequalities in mortality and morbidity
into middle and old age [19]. Our study explicitly compared changes in smoking behavior between white,
black, and Latino older adults, and we did not find that
blacks or Latinos were less likely to quit or reduce
smoking levels relative to whites. Our findings provide
support for better access to smoking cessation counseling and therapies for middle-aged and older adults
regardless of race/ethnic background, but may warrant
particular emphasis on whites whom we found less
likely to quit smoking after suffering a stroke, and who
smoke 1.5 to nearly 2 times as many cigarettes as
blacks after newly diagnosed diabetes, cancer, heart disease or stroke.
Our findings suggest there may be differences in
smoking behavior change after the diagnosis of specific
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chronic diseases, but we could not ascertain why or how
this occurred. Based on other research, we can speculate
about several potential explanations. There may be differences in the importance assigned to the diffusion of
smoking cessation counseling by clinicians in the face of
critical health events, such as a stroke. In addition, the
ability to react to adverse health events and assimilate
health warnings brought on by a recent diagnosis or
health decline may be constrained for some individuals.
Lack of access to timely smoking cessation counseling
may have important repercussions for secondary prevention efforts to avert poor health outcomes for older
adults [31]. While our results do not speak to the causes
of continuing, stopping, or reducing smoking behaviors,
our overall findings imply that middle-aged and older
adults may have different patterns of smoking, may have
other deterrents to stopping smoking, may not be effectively targeted by smoking interventions, or may have different perspectives on the effects of smoking on health [31].
This study contributes to the understanding of health
behaviors in important ways, and draws from a number
of strengths. First, the prospective study design assesses
health behaviors prior to the diagnosis of the condition
and is less susceptible to recall and social desirability
biases. Second, this study compares lifestyle changes
among the most serious chronic conditions, an improvement over many earlier studies that examine health conditions in isolation. Third, the consideration of racial and
ethnic group differences in smoking behavior change in
response to chronic disease onset provides important insights on reducing subsequent health risks for white, black,
and Latino older adults. Finally, this study contributes to
the understanding of whether behavioral processes are
similar or different for minority and white individuals and
where improvements in chronic disease management are
most needed.
Several limitations should also be noted. First, our measures of health conditions, including disease diagnosis and
smoking behaviors were derived from self- report. To the
extent that there is under-reporting of health conditions
[32], any bias would likely overestimate changes in
smoking behavior, because individuals with pre-clinical
indications of disease (e.g., pre-diabetes) would not
have been included and might be less likely to receive
repeated smoking cessation messaging or would be less
motivated to change. However, several studies have
shown reasonable concordance between self-reported
chronic conditions and other methods of ascertainment
[33–35]. Second, the present study is not a matchedcohort controlled study, therefore we should be cautious in attributing changes in smoking behavior to new
disease onset. However, the objective of our study was
not to examine smoking cessation outcomes relative to
controls who are not diagnosed with chronic disease.
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There is a higher likelihood of cessation that has been
shown relative to controls in a previous study [18]. In
the present study, we instead compare smoking changes
over a 2-year window around a new chronic disease
diagnosis between black, white, and Latino middle-aged
and older adults in the US. Third, our data do not permit
examination of quit attempts in our study. Cessation
attempts may vary for individuals from underrepresented
racial/ethnic background due to compounding influences
with poor socioeconomic status, low literacy levels, lack of
access to environments that are conducive to healthful
lifestyles, not receiving important health messages from
their health providers that are delivered in appropriate
ways, and lack of access to and use of smoking cessation
therapies. Further, success in quitting (i.e., lack of reinitiation) is more likely to occur for adults with greater
socioeconomic resources [36]. While we cannot assess
cessation attempts, our study examines cessation and
changes in smoking amounts around a critical clinical
diagnostic window, which represents useful and actionable
information to intervene on older smokers after they have
developed a chronic condition. Finally, our study involves
new diagnosis of serious health conditions; however, it is
unknown whether individuals made lifestyle changes prior
to diagnosis. Some individuals may reduce or quit smoking after receiving health warnings such as repeated high
blood pressure or cholesterol measurements. Inclusion of
medical record information of pre-diagnosis risk factors
along with subsequent diagnosis of major conditions in
future studies would provide important new information
about whether or when individuals change behavior at
earlier points of disease development.
There may be important extensions to this study that
should be addressed in future work. While our study examined differences in changes to smoking after chronic
disease onset between white, black, and Latino Americans, it is also important to understand the predictors
and determinants of changes to smoking behaviors for
each of these racial and ethnic background groups.
Future studies should address important factors that
predict cessation and smoking reductions for black,
white, and Latino older adults. In addition, there may be
important dynamics to smoking cessation and smoking
reductions for middle-aged and older men and women,
and for men and women from different racial/ethnic backgrounds. These considerations should also be addressed in
future studies.

Conclusions
Overall, the post-diagnosis reductions in smoking for
white and black adults in middle and late life are encouraging, and indicate that the onset of a diagnosis may be an
actionable or “teachable moment” for smokers to change.
Onset of a new chronic condition is not an uncommon
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occurrence for middle-aged and older adults and should
provide an important opportunity to address smoking cessation in the clinical setting at the time of a new diagnosis.
Greater efforts should be made to reach older adults once
chronic diseases have set in, possibly through increased
efforts at reaching these populations with access to
appropriate smoking cessation messaging and therapies.
Additional research can identify the most effective
strategies for cessation interventions in the context of
incident chronic disease.
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